What's Happening?
K-pop group ENHYPEN has announced the venue and ticketing details for their upcoming world tour, 'BLOOD SAGA'. The tour will include stops in Latin America, the United States, the UK, and Europe. The tour is set to begin on May 1, 2026, at the KSPO Dome
in Seoul with three sold-out shows. In the United States, the group will perform in cities including Dallas, San Diego, Tacoma, Oakland, and Las Vegas. The tour will continue into 2027 with performances in major European cities such as Milan, Paris, Amsterdam, Berlin, and London. ENHYPEN's previous tour, 'WALK THE LINE', was a significant success, drawing over 676,000 fans across 32 shows in 19 countries. The group is known for its global appeal and has sold out shows in the U.S. and Europe, solidifying their status as international stars.
Why It's Important?
The announcement of ENHYPEN's 'BLOOD SAGA' tour is significant as it highlights the growing influence of K-pop on the global music scene, particularly in the United States and Europe. The tour provides an opportunity for the group to expand their fan base and connect with ENGENE, their dedicated fandom, in new regions. This move is likely to boost the group's international profile and contribute to the increasing popularity of K-pop worldwide. The tour's success could also have economic implications, as concerts and related events generate substantial revenue for local economies through ticket sales, merchandise, and tourism.
What's Next?
Fans interested in attending the 'BLOOD SAGA' tour can participate in the ENGENE membership presale, which requires prior application on Weverse. The presale for U.S. fans will occur from April 22 to April 23, 2026, with the general sale starting on April 24, 2026. The tour's success will likely influence future tour planning and the selection of cities, potentially leading to more diverse and widespread tour locations in subsequent years. Additionally, the tour's reception may impact ENHYPEN's future projects and collaborations within the music industry.












